NEW YORK , Aug. 23, 2024 /PRNewswire/ -- The global epedigree software market size is estimated to grow by USD 4.02 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of 18.69% during the forecast period. Rising requirements for serializability to tackle counterfeiting is driving market growth, with a trend towards high-tech developments to smarten pharma supply chain.
However, huge time and cost requirements for infrastructural implementation poses a challenge. Key market players include Altair Engineering Inc., ANSYS Inc.
, Antares Vision S.p.A, Aptean Group of Companies, Axway Software SA, Bar Code Integrators Inc.
, Blue Yonder Inc., Labeling Systems LLC, Merit Solutions Inc., Microsoft Corp.
, Optel Group, Oracle Corp., rfxcel Corp., SAP SE, Siemens AG, and TraceLink Inc.
. Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report Market Driver The global pharma industry faces a significant challenge with the proliferation of counterfeit drugs, estimated to be worth billions of dollars. This issue persists due to the intricate pharmaceutical supply chain, which lacks adequate quality control.
Forgeries, drug redirection, and other related concerns are on the rise, posing a threat to consumer trust and the industry's integrity. The pharma industry itself suffers from substantial losses due to the counterfeit market. To address these challenges, ePedigree software has emerged .